Table 2.
All progeny
| |||||||
---|---|---|---|---|---|---|---|
CQ IC50 vs. | VP | CLM | CT | CQ+VP fold change | CQ+CLM fold change | CQ+CT fold change | CQ+AM fold change |
r | -0.72 | -0.95 | -0.92 | 0.98 | 0.98 | 0.98 | 0.98 |
p value | *** | *** | *** | *** | *** | *** | *** |
| |||||||
CQS progeny
| |||||||
CQS IC50 vs. | VP | CLM | CT | CQ+VP fold change | CQ+CLM fold change | CQ+CT fold change | CQ+AM fold change |
r | 0.37 | 0.49 | 0.53 | 0.32 | 0.42 | 0.34 | 0.45 |
p value | 0.12 | 0.03 | 0.02 | 0.19 | 0.07 | 0.15 | 0.06 |
| |||||||
CQR progeny
| |||||||
CQR IC50 vs. | VP | CLM | CT | CQ+VP fold change | CQ+CLM fold change | CQ+CT fold change | CQ+AM fold change |
r | 0.48 | 0.55 | 0.75 | 0.15 | 0.02 | 0.08 | 0.04 |
p value | 0.06 | 0.03 | 0.0001 | 0.59 | 0.93 | 0.78 | 0.89 |
VP, CLM, and CT represent IC50 values of reversal agents when used alone (i.e. potency)
Correlation analysis reported as Pearson’s correlation coefficient reported as an r value, and the p value determining if significantly deviating from zero.
p < 0.0001